INCY logo

INCYTE CORP

INCYNASDAQ
🏆 #490 by market capEarnings Oct 26🧬Biotech
$122.34▼ $2.43 (−1.99%)
Live
🔔
Track INCY
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 2.0%
7d▼ 3.6%
14d▲ 0.5%
30d▼ 1.6%
ytd▲ 23.8%
1y▲ 45.9%
🏦Market Cap
$24.80B
Mid Cap
📈Revenue Growth (YoY)
+21.2%
Healthy
📊Gross Margin
92.6%
High
💵FCF Margin
33.0%
Strong
⚖️P/S Ratio
4.3x
Fair
Otter Score
60
Fair
INCY logo

INCYTE CORP

INCY
Analyst Ratings
Price
$122.34
Total
44
Raised
4
Lowered
4
Avg PT
$130.21
H / L
$155 / $104
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-28
—
—
JP Morgan
Reiterated · Neutral · 2026-09-28
—
—
RBC Capital
Reiterated · Sector Perform · 2026-09-22
$109.00
−10.90%
Piper Sandler
Reiterated · Overweight · 2026-08-17
$130.00
+6.30%
Mizuho
Reiterated · Outperform · 2026-08-04
—
—
Leerink Partners
Reiterated · Outperform · 2026-08-03
$155.00
+26.70%
Guggenheim
Reiterated · Buy · 2026-07-29
$150.00
+22.60%
BMO Capital
Reiterated · Market Perform · 2026-07-29
$130.00
+6.30%
Barclays
Reiterated · Overweight · 2026-07-29
$139.00
+13.60%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-23
$119.00
−2.70%
UBS
Reiterated · Neutral · 2026-06-26
$113.00
−7.60%
Truist Securities
Reiterated · Hold · 2026-06-22
—
—
Stifel
Reiterated · Buy · 2026-04-29
—
—
Oppenheimer
Reiterated · Perform · 2026-04-29
$120.00
−1.90%
Jefferies
Downgraded · Buy → Hold · 2026-03-16
$84.00
−31.30%
Evercore ISI Group
Reiterated · In Line · 2026-03-05
—
—
Wells Fargo
Reiterated · Equal Weight · 2026-02-11
$107.00
−12.50%
TD Cowen
Reiterated · Buy · 2026-01-13
—
—
B of A Securities
Reiterated · Buy · 2025-09-04
—
—
Citigroup
Reiterated · Buy · 2025-07-30
$97.00
−20.70%
William Blair
Downgraded · Outperform → Market Perform · 2025-03-18
—
—
Citizens Capital Markets
Reiterated · Market Perform · 2025-03-11
—
—
JMP Securities
Reiterated · Market Perform · 2025-02-11
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2025-01-10
$79.00
−35.40%
Goldman Sachs
Reiterated · Neutral · 2024-10-30
$90.00
−26.40%
Deutsche Bank
Reiterated · Hold · 2024-08-01
$55.00
−55.00%
SVB Leerink
Reiterated · Underperform · 2023-03-20
—
—
Credit Suisse
Reiterated · Buy · 2023-02-16
—
—
Cowen & Co.
Reiterated · Outperform · 2023-02-08
$100.00
−18.30%
Benchmark
Upgraded · Hold → Buy · 2021-07-20
—
—
Guggenheim Securities
Downgraded · Buy → Neutral · 2020-01-02
—
—
Nomura
Reiterated · Buy · 2019-07-31
—
—
Stifel Nicolaus
Reiterated · Hold · 2019-04-11
$145.00
+18.50%
Argus
Reiterated · Buy · 2019-02-25
—
—
Argus Research
Reiterated · Buy · 2019-02-25
$70.00
−42.80%
Gabelli & Co.
Upgraded · Hold → Buy · 2019-01-24
—
—
Leerink Swann
Reiterated · Market Perform → Perform · 2018-09-25
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2017-09-11
—
—
PiperJaffray
Downgraded · Overweight → Neutral · 2017-04-17
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2016-08-05
—
—
Brean Capital
Reiterated · Buy · 2016-02-12
—
—
Bank of America
Reiterated · Buy · 2015-05-29
—
—
Lazard
Upgraded · Neutral → Buy · 2013-01-14
—
—
Canaccord Genuity
Reiterated · Buy · 2012-04-26
$152.00
+24.20%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space